France· FR:63708322
MOXONIDINE TEVA SANTE 0,2 mg, comprimé pelliculé
A moxonidine product containing moxonidine, registered in France by RATIOPHARM (ALLEMAGNE), on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Moxonidine is registered in 13 of 19 countries.
Countries holding a registration under ATC C02AC05 (moxonidine), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 8 of them publish a price we can compare per daily dose
Moxonidine · ATC C02AC05
13 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of moxonidine costs, country by country.
Normalised to the WHO defined daily dose (0.3 mg), the median price runs from $0.19 in France to $0.70 in Switzerland — a ×3.7 gap.
- France: $0.19 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Moxonidine · price per daily dose (0.3 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.70
- IT Italy$0.35
- FR France$0.19
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- MOXONIDINE
- Manufacturer
- RATIOPHARM (ALLEMAGNE)
- Country
- France (FR)
- ATC code
- C02AC05
- ATC class
- Moxonidine
- Defined daily dose
- 0.3 mg, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cip133400937450607plaquette(s) PVC PVDC aluminium de 30 comprimé(s)EUR 3.64
- cip133400937450836plaquette(s) PVC PVDC aluminium de 90 comprimé(s)EUR 10.53
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Moxonidine in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCYNTVIATRIS HEALTHCARE LIMITED, Dublin
- FinlandMoxonidin EpipharmEpipharm Oy
- PolandPhysiotens 0,2Medezin Sp. z o.o.
- BelgiumMoxonidine EG 0.2 mgEG
- NetherlandsMoxamar 0,2 mg, filmomhulde tablettenTeva Pharma B.V.
- SwedenMoxonidin Actavis 0,2 mg Filmdragerad tablettActavis Group PTC ehf.
- NorwayMoxonidin ActavisActavis Group PTC ehf (1)
- ItalyFISIOTENSVIATRIS ITALIA S.R.L.
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Moxonibene, Moxonidin Stada
- Belgium · Moxonidine Eg, Moxonidine Sandoz
- Bulgaria · Moxotens, Moксотенс
- Cyprus · Physiotens, Tarwoxin
- Czechia · Cynt, Moxonidin Actavis
- Germany · Moxogamma, Moxonidin 1 A Pharma
- Denmark · Moxonat, Moxonidin Teva
- Estonia · Moxogamma, Moxonidin Actavis
- Spain · Moxon
- Finland · Moxonidin Ratiopharm, Moxonidin Stada
- United Kingdom (Northern Ireland) · Moxonidine, Moxonidine Generics [uk]
- Greece · Cynt, Fisiotens
- Croatia · Cynt, Moksonidin Belupo
- Hungary · Moxogamma, Moxonidin Ratiopharm
- Italy · Fisiotens, Moxonidina Eg
- Lithuania · Moxogamma, Moxonidin Hexal
- Luxembourg · Moxonidine Eg, Moxonidine Viatris
- Latvia · Moxogamma, Moxonidin Actavis
- Malta · Physiotens
- Netherlands · Moxamar, Moxonidine Pch
- Norway · Moxonidin Actavis, Physiotens
- Poland · Physiotens
- Portugal · Moxon
- Romania · Physiotens
- Sweden · Moxonidin Actavis, Moxonidin Stada
- Slovenia · Filmsko Obložene Tablete, Moxogamma, Moxogamma
- Slovakia · Moxogamma, Moxonidin Ratiopharm
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ddd55c5a-bb8e-4654-93cb-6a8344f5e201 GET /v1/drugs/ddd55c5a-bb8e-4654-93cb-6a8344f5e201?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "63708322",
"date_amm": "2006-03-20",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "MOXONIDINE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about moxonidine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.